Highest-materiality recent filing
Crescent BDC Q2 2026 NII $0.36/sh, net loss $0.09/sh; regular dividend cut to $0.34
Net investment income per share $0.36, down from $0.42 in Q1 and $0.46 in Q2 2025; net loss $(0.09) vs +$0.41 year-ago.
Crescent Capital BDC prepays $50M of 7.54% senior notes due July 2026
Prepaid $50.0M aggregate principal of 7.54% senior unsecured notes due July 28, 2026.
Crescent Capital BDC increases SMBC revolving credit facility commitments to $165M
Dollar commitments under senior secured revolving facility increased from $140M to $165M.
Crescent Capital BDC ups credit facility to $500M, issues $50M notes, repays $111.6M
Ninth Amendment increases borrowing facility from $400M to $500M; spread rises from 1.95% to 2.00%.
Crescent Capital BDC reports 2026 annual meeting voting results
Directors Susan Yun Lee and Michael S. Segal elected as Class II directors for three-year terms.
Net investment income of $15.5M ($0.42/share) vs $16.5M ($0.45) prior quarter; net loss of ($15.5M) or ($0.42)/share.
Director Ko resigns; CEO Breaux and President Chung elected to board
Elizabeth Ko resigned as director effective May 5, 2026; no disagreement with management or operations.
Crescent Capital BDC closes $135M senior notes issuance; swaps to floating rate
Issued $67.5M Tranche A notes at 5.87% due Feb 2029 and $67.5M Tranche B notes at 6.20% due Feb 2031.
Crescent BDC Q4 NII $0.45, full-year $1.81; NAV $19.10; Q1 dividend $0.42
Full-year net investment income $66.9M, or $1.81 per share, down from $2.40 in 2024.
Crescent Capital BDC Reports Q3 2025 Net Investment Income of $0.46 Per Share
Net investment income per share $0.46 for Q3 2025, down from $0.64 in Q3 2024.
Crescent Capital BDC issues $185M in senior unsecured notes across three tranches
Tranche A: $67.5M at 5.87%, due Feb 13, 2029; Tranche B: $67.5M at 6.20%, due Feb 13, 2031; Tranche C: $50M at 5.97%, due May 22, 2029.
Crescent Capital BDC reports Q2 2025 net investment income of $0.46 per share, NAV $19.55
Net investment income for Q2 2025 was $0.46 per share, including $0.02 of one-time accelerated amortization
Shareholders elect Briscoe and Strong as Class I directors; ratify E&Y auditor
Class I directors Kathleen S. Briscoe and George G. Strong, Jr. elected to three-year terms expiring at 2028 annual meeting.
Crescent BDC Q1 NII $0.45/sh; NAV down to $19.62; declares $0.42 base dividend
Net investment income of $0.45 per share; net income of $0.11 per share for Q1 2025.
Crescent Capital BDC amends credit facility: spread cut 50bps, size reduced to $400M
Eighth Amendment to Loan and Security Agreement with Wells Fargo executed April 10, 2025.
Crescent Capital BDC Q4 NII $0.55/shr; declares $0.42 base plus $0.15 special dividends
Q4 2024 net investment income $0.55/shr; net income $0.27/shr; NAV per share $19.98 (down from $20.20 prior qtr).
Crescent Capital BDC issues $115M senior notes at 6.77% and 6.90%
$35M 6.77% notes due Feb 18, 2028; $80M 6.90% notes due Feb 18, 2030.
Crescent Capital BDC amends credit facility, extends maturity to 2029, adds $25M term loan
Revolving commitment reduced from $350M to $285M; new $25M term commitment added; total facility $310M.
NII per share $0.64 (up from $0.59 Q3 2023); net income $0.41 vs $0.61 a year ago.
Crescent Capital BDC Q2 NII $0.59/sh, NAV $20.30; declares $0.42 base + $0.09 supplemental dividend
Net investment income per share $0.59 (up from $0.56 YoY); net income per share $0.55.
Crescent Capital BDC replaces analyst day replay with transcript after technical issues
Amendment dated June 17, 2024 corrects original June 11 8-K: replay unavailable due to technical issues.
Crescent Capital BDC holds Analyst & Investor Day on June 11, 2024; deck posted on website
Analyst & Investor Day held on June 11, 2024 via live video stream at 6:00 PM ET.
Reinvestment period extended to May 31, 2027; stated maturity to May 31, 2029.
Crescent Capital BDC stockholders elect Class III directors and ratify auditor
Elizabeth Ko elected as Class III director with 17,157,771 for, 193,647 withheld, 6,912,316 broker non-votes.
Crescent Capital BDC Q1 NII $0.63/share; NAV $20.28; raises quarterly dividend by $0.01
Net investment income of $0.63/share vs $0.54/share in Q1 2023; net income $0.76/share.
Crescent Capital BDC Q4 net investment income $0.61/sh; NAV $20.04; appoints Henry Chung President
Q4 net investment income $0.61/share ($22.8M) vs $0.52/share YoY; net income $0.83/share.
Net investment income of $21.7 million ($0.59 per share) for quarter ended September 30, 2023, up from $0.56 in prior quarter.
Net investment income of $20.6M ($0.56 per share) vs $0.50 per share in Q2 2022.
Crescent Capital BDC issues $50M 7.54% senior notes due 2026, repays $51.5M in 5.95% notes
Issued $50M aggregate principal of 7.54% senior unsecured notes due July 28, 2026.
Crescent Capital BDC shareholders elect directors, ratify auditor at 2023 annual meeting
Susan Y. Lee and Michael S. Segal elected as Class II directors; terms expire at 2026 annual meeting.
Crescent Capital BDC Q1 NII $0.54/share; NAV $19.38; completed First Eagle BDC acquisition
Net investment income $17.5M ($0.54/share) vs. $0.52 prior quarter and $0.39 year-ago quarter.
Crescent BDC has no cash accounts, deposits, or credit facilities with Silicon Valley Bank or Signature Bank.
Crescent Capital BDC completes merger with First Eagle BDC; combined assets >$1.6B
FCRD stockholders received $0.29 cash, 0.20635 CCAP shares, and $1.17 transaction support per share.
Crescent Capital BDC increases credit facility commitments from $350M to $500M
Sixth Amendment to Loan and Security Agreement ups total commitments from $350 million to $500 million.
Crescent Capital BDC reports Q4 2022 NII of $0.52/share; declares $0.41 dividend
Q4 2022 net investment income $16.1M ($0.52/share); adjusted NII $15.0M ($0.49/share).
Crescent Capital BDC increases revolving credit facility from $350M to $385M
Amended credit facility with Sumitomo Mitsui Banking Corp increases commitment to $385 million from $350 million.
Crescent BDC Q3 NII $0.52/share, NAV $20.16; declares $0.41 dividend; appoints new CCO
Net investment income of $16.0M ($0.52/share); adjusted NII $13.0M ($0.42/share).
Crescent Capital BDC to acquire First Eagle Alternative Capital BDC in stock/cash deal
Combined company expected to have ~$1.6B of investments on a pro forma basis.
Crescent Capital BDC Q2 NII $0.50/share vs $0.39 prior; declares $0.41 regular dividend
Net investment income of $15.5M ($0.50/share) up from $12.1M ($0.39/share) in Q1 2022; adjusted NII $12.7M ($0.41/share).
Crescent Capital BDC appoints Susan Yun Lee as independent Class II director
Board expanded from 5 to 6 members; Lee fills the new vacancy.
Crescent Capital BDC elects Briscoe, Strong, Ko as directors; ratifies E&Y auditor
Kathleen S. Briscoe and George G. Strong, Jr. elected as Class I directors for three-year terms (21.95M and 21.73M votes for).
Crescent BDC Q1 NII $0.39/share; Adj NII $0.42; NAV $21.18; declares $0.41 dividend
NII of $12.1M ($0.39/share); Adjusted NII $12.9M ($0.42/share).
Crescent Capital BDC ups revolving credit facility to $350M from $300M
Credit facility increased by $50M to $350M under amendment dated March 4, 2022.
Crescent Capital BDC Q4 2021 NII $0.42/share, down from $0.47 YoY; declares $0.41 dividend
Q4 2021 net investment income $12.5M ($0.42/share) vs $13.2M ($0.47/share) in Q4 2020.
Sun Life commits up to $10M in second stock purchase program for Crescent Capital BDC
Sun Life, majority owner of Crescent's investment advisor, authorizes second $10M open-market purchase plan for CCAP common stock.
Crescent Capital BDC issues 2.5M shares in public offering, netting $52.8M
Issued 2.5M shares of common stock at $21.33 per share, net proceeds approx. $52.8M after expenses.
Crescent BDC reports Q3 NII $0.45/sh, declares $0.41 regular + $0.05 special dividends
Net investment income $12.7M ($0.45/sh); Adjusted NII $13.5M ($0.48/sh).
Crescent Capital BDC enters $300M revolving credit facility, terminates Ally Bank facility
New $300 million senior secured revolving credit facility with Sumitomo Mitsui Banking Corporation as admin agent and lender.
Crescent Capital BDC Q2 NII $0.39/share; declares $0.41 Q3 dividend
Net investment income $11.0M ($0.39/share); adjusted NII $14.8M ($0.53/share).
Crescent Capital BDC appoints Jason Breaux President, elects Elizabeth Ko Chairman
Christopher Wright resigned as director effective June 30, 2021; no disagreement with management.
On and effective as of 12:00 a.m. midnight on May 5, 2026, the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Elizabeth Ko as a member of the Board and a Class III Director.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Jason Breaux as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
On and effective as of 1:00 p.m. on May 7, 2026, the Board elected Mr. Henry Chung as a Class III director, which is the class of directors that will stand for election at the Company’s 2027 Annual Meeting of Stockholders, or until a successor is duly elected and qualified.
Mr. Chung succeeds Jason Breaux as the Company’s President. Mr. Breaux continues in his role as the Company’s Chief Executive Officer.
Effective February 15, 2024, the Board of Directors of the Company appointed Henry Chung, age 36, as its President.
Additionally, as of the Effective Date, the Board appointed Erik Barrios as the Company's Chief Compliance Officer.
On and effective as of November 4, 2022 (the "Effective Date"), the Board of Directors (the "Board") of Crescent Capital BDC, Inc. (the "Company") accepted the resignation of Joe Hanlon as the Chief Compliance Officer.
appointed Susan Yun Lee as an independent Class II director to fill the vacancy created by such increase.
the Board elected Ms. Elizabeth E. Ko as a Class III director, which is the class of directors that will stand for election at the Company’s 2024 Annual Meeting of Stockholders, or until a successor is duly elected and qualified. Ms. Ko, who will serve as Chairman of the Board
the Board appointed Jason A. Breaux as the Company’s President.
the Board of Directors (the “Board”) of Crescent Capital BDC, Inc. (the “Company”) accepted the resignation of Christopher G. Wright as a member of the Board.
Max materiality 0.85 · Median 0.55 · Most common event earnings